EU-Funding: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema

With this funding Micreos can accelerate the availability of its innovative products - marketed under the Gladskin brand - for inflammatory skin conditions such as acne, eczema and rosacea.